Researcher
Pierre Van Mol
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Cancer diagnosis
- See also: Pierre Van Mol (Flanders Institute for Biotechnology)
Affiliations
- Laboratory of Translational Genetics (VIB-KU Leuven) (Division)
Member
From1 Nov 2019 → Today - Lambrechts Lab (Research group)
Member
From1 Aug 2019 → 31 Oct 2023 - Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) (Division)
Member
From1 Aug 2019 → 31 Oct 2019
Projects
1 - 1 of 1
- A single-cell approach to identify biomarkers of efficacy and toxicity for immune checkpoint blockade in non-small cell lung cancer.From1 Aug 2019 → 1 Aug 2023Funding: FWO Strategic Basic Research Grant, Foundations, funds and other with scientific goal
Publications
1 - 10 of 20
- Single-cell phenotyping to unravel the immunopathology of immune checkpoint inhibitor-related pneumonitis. Lessons learnt from the COVID-19 pandemic(2023)
Authors: Pierre Van Mol, Els Wauters, Johan Vansteenkiste, Diether Lambrechts
- Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients.(2023)
Authors: Seppe Cambier, Fabio Beretta, Ana Carolina De Carvalho, Janne Kaes, Pierre Van Mol, Els Wauters, Greet Hermans, Bart Vanaudenaerde, Robin Vos, Joost Wauters, et al.
- C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps(2023)
Authors: Seppe Cambier, Fabio Beretta, Pierre Van Mol, Simon Feys, Els Wauters, Diether Lambrechts, Paul Proost
- A pan-cancer single-cell tumor micro-environment atlas predictive of immunotherapy response(2023)
Authors: Sam Vanmassenhove, Pierre Van Mol, Sarah Cappuyns, Liselore Loverix, Hanne Vos, Diether Lambrechts
- The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution(2023)
Authors: Bram Boeckx, Sander Jansen, Simon Feys, Stijn Verleden, Laurens Liesenborghs, Sébastien Dumas, Mila Borri, Liliana Sokol, Anh-Co Truong, Jan Gunst, et al.
Pages: 520 - 535 - Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates(2022)
Authors: Kourosh Ahmadzadeh, Bram Boeckx, Amber De Visscher, Eline Bernaerts, Pierre Van Mol, Yannick Van Herck, Greet Hermans, Alexander Wilmer, Mieke Gouwy, Abhishek Garg, et al.
- Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis(2022)
Authors: Pierre Van Mol, Sam Vanmassenhove, Christophe Dooms, Dries Testelmans, Kristiaan Nackaerts, Johan Vansteenkiste, Robin Vos, Stephanie Humblet-Baron, Diether Lambrechts, Els Wauters
- Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19(2022)
Authors: Caroline Martens, Pierre Van Mol, Joost Wauters, Els Wauters, Laurens Liesenborghs, Elisabeth Heylen, Sander Jansen, Sirima Kraisin, Robin Vos, Christophe Vandenbriele, et al.
- Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches(2022)
Authors: Pierre Van Mol, Els Wauters, Johan Vansteenkiste
Pages: 893 - 908 - Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19(2022)
Authors: Pierre Van Mol, Els Wauters, Laurens Liesenborghs, Robin Vos, Greet Hermans, Alexander Wilmer, Kim Martinod, Peter Verhamme, Johan Neyts, Thomas Vanassche